Evidence map›Paper›PMID 19524160›Full record

ArticleAmerican journal of preventive medicine2009

Effects of apolipoprotein E genotype on blood cholesterol in adolescent girls.

Janet E Fulton, Shifan Dai, Jo Anne Grunbaum, Eric Boerwinkle, Darwin R Labarthe

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The apolipoprotein E gene and Taq1A polymorphisms in childhood obesity.Genetic testing and molecular biomarkers · 2010
    Article
  7. Findings from Project HeartBeat! Their importance for CVD prevention.American journal of preventive medicine · 2009
    Article
  8. Project HeartBeat! Concept, development, and design.American journal of preventive medicine · 2009
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Janet E FultonDivision of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341-3724, USA. jkf2@cdc.gov
Shifan Dai
Jo Anne Grunbaum
Eric Boerwinkle
Darwin R Labarthe
CDC Foundation · USCenters for Disease Control and Prevention · USThe University of Texas Health Science Center at Houston · US

Funding

PEDIATRIC EPIDEMIOLOGY OF CVD RISK FACTORSU01HL041166 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LABARTHE, DARWIN R. · 1990 to 1995
–
NHLBI NIH HHS U01 HL041166NHLBI NIH HHS U01-HL-41166PHS HHS U48/CCU609653
6 · The paper itself

Abstract

backgroundFew investigations have examined whether associations between the apolipoprotein E genotype (apo E) and total cholesterol or LDL-C are modified or explained by other characteristics. The objective of this study was to explore effects of behavioral characteristics, physical growth, body composition, sexual maturation, and endocrine function on age trajectories of total cholesterol and LDL-C by apo E in adolescent girls.

methodsParticipants were 247 Caucasian adolescent girls followed for 4 years. Apo E genotyping and plasma lipid concentrations were determined from fasting blood samples using standard enzymatic methods. Age; gender; fat-free mass (FFM); BMI; percent body fat (PBF); sexual maturation (pubic hair, Tanner Stages 1-5); estradiol concentration (EST); energy intake; and physical activity were collected or calculated with standard methods.

resultsIn models including the proposed explanatory variables, apo E genotype remained strongly associated with total cholesterol and LDL-C. Girls with the epsilon (epsilon)3/3 and epsilon3/4 genotypes (where epsilon is the protein isoform of the apo E gene), relative to those with epsilon2/3, had total cholesterol and LDL-C values 16-23 mg/dL higher throughout adolescence. Age-apo E interaction terms remained significant. FFM, BMI, PBF, pubic-hair stage, and EST showed a significant effect on total cholesterol and LDL-C. When the combination of pubic-hair stage, EST, and one of FFM, BMI, and PBF was included in total cholesterol or LDL-C models, only EST was significant.

conclusionsAdolescent girls with epsilon3/3 and epsilon3/4 genotypes had higher total cholesterol and LDL-C and showed different patterns of change, compared to those with epsilon2/3 genotype. These apo E effects were independent of behavioral characteristics, physical growth, body composition, sexual maturation, and endocrine function. Girls with epsilon3/3 or epsilon3/4 genotypes may be at risk for elevated total cholesterol and LDL-C later in life.

Indexed as

Adipose TissueAdolescentAge FactorsApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Body CompositionBody Mass IndexChildCholesterolCholesterol, LDLEndocrine SystemFemaleFollow-Up StudiesGenotypeHumansApolipoprotein E2Apolipoprotein E3Apolipoprotein E4CholesterolCholesterol, LDL

Identifiers

PMID19524160
PMCPMC4351740
OpenAlexW2047543243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.